3.23.1 html 248 347 1 false 88 0 false 7 false false R1.htm 100000 - Document - Cover Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DocumentCover Cover Cover 1 false false R2.htm 100010 - Statement - Consolidated Balance Sheets (Unaudited) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_StatementConsolidatedBalanceSheetsUnaudited Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 100030 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_StatementConsolidatedBalanceSheetsUnauditedParenthetical Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 100040 - Statement - Consolidated Statements of Operations (Unaudited) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsUnaudited Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 100050 - Statement - Consolidated Statements of Comprehensive Loss (Unaudited) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited Consolidated Statements of Comprehensive Loss (Unaudited) Statements 5 false false R6.htm 100060 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficitUnaudited Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) Statements 6 false false R7.htm 100070 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/StatementConsolidatedStatementsOfCashFlowsUnaudited Consolidated Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 100080 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies Basis of Presentation and Summary of Significant Accounting Policies Notes 8 false false R9.htm 100090 - Disclosure - Liquidity and Going Concern Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureLiquidityAndGoingConcern Liquidity and Going Concern Notes 9 false false R10.htm 100100 - Disclosure - Fair Value Measurements Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurements Fair Value Measurements Notes 10 false false R11.htm 100110 - Disclosure - Investments Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureInvestments Investments Notes 11 false false R12.htm 100120 - Disclosure - Goodwill and Intangible Assets Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureGoodwillAndIntangibleAssets Goodwill and Intangible Assets Notes 12 false false R13.htm 100130 - Disclosure - Significant Agreements and Contracts Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureSignificantAgreementsAndContracts Significant Agreements and Contracts Notes 13 false false R14.htm 100140 - Disclosure - Debt Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureDebt Debt Notes 14 false false R15.htm 100150 - Disclosure - Stockholders' Equity Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureStockholdersEquity Stockholders' Equity Notes 15 false false R16.htm 100160 - Disclosure - Stock-Based Compensation Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureStockbasedCompensation Stock-Based Compensation Notes 16 false false R17.htm 100170 - Disclosure - Commitments and Contingencies Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 17 false false R18.htm 100180 - Disclosure - Income Taxes Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureIncomeTaxes Income Taxes Notes 18 false false R19.htm 100190 - Disclosure - Net Loss Per Share Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureNetLossPerShare Net Loss Per Share Notes 19 false false R20.htm 100200 - Disclosure - Segment Information Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureSegmentInformation Segment Information Notes 20 false false R21.htm 100210 - Disclosure - Liabilities Subject to Compromise Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureLiabilitiesSubjectToCompromise Liabilities Subject to Compromise Notes 21 false false R22.htm 100220 - Disclosure - Reorganization Items, Net Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureReorganizationItemsNet Reorganization Items, Net Notes 22 false false R23.htm 100230 - Disclosure - Condensed Combined Debtor-In-Possession Financial Information Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureCondensedCombinedDebtorinpossessionFinancialInformation1 Condensed Combined Debtor-In-Possession Financial Information Notes 23 false false R24.htm 100240 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies Basis of Presentation and Summary of Significant Accounting Policies (Policies) Policies http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies 24 false false R25.htm 100250 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables Basis of Presentation and Summary of Significant Accounting Policies (Tables) Tables http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies 25 false false R26.htm 100260 - Disclosure - Fair Value Measurements (Tables) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurements 26 false false R27.htm 100270 - Disclosure - Goodwill and Intangible Assets (Tables) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureGoodwillAndIntangibleAssetsTables Goodwill and Intangible Assets (Tables) Tables http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureGoodwillAndIntangibleAssets 27 false false R28.htm 100280 - Disclosure - Debt (Tables) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureDebtTables Debt (Tables) Tables http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureDebt 28 false false R29.htm 100290 - Disclosure - Stock-Based Compensation (Tables) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureStockbasedCompensationTables Stock-Based Compensation (Tables) Tables http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureStockbasedCompensation 29 false false R30.htm 100300 - Disclosure - Commitments and Contingencies (Tables) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureCommitmentsAndContingencies 30 false false R31.htm 100310 - Disclosure - Net Loss Per Share (Tables) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureNetLossPerShareTables Net Loss Per Share (Tables) Tables http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureNetLossPerShare 31 false false R32.htm 100320 - Disclosure - Segment Information (Tables) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureSegmentInformationTables Segment Information (Tables) Tables http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureSegmentInformation 32 false false R33.htm 100330 - Disclosure - Liabilities Subject to Compromise (Tables) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureLiabilitiesSubjectToCompromiseTables Liabilities Subject to Compromise (Tables) Tables http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureLiabilitiesSubjectToCompromise 33 false false R34.htm 100340 - Disclosure - Reorganization Items (Tables) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureReorganizationItemsTables Reorganization Items (Tables) Tables http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureReorganizationItemsNet 34 false false R35.htm 100350 - Disclosure - Condensed Combined Debtor-In-Possession Financial Information (Tables) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureCondensedCombinedDebtorinpossessionFinancialInformationTables Condensed Combined Debtor-In-Possession Financial Information (Tables) Tables http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureCondensedCombinedDebtorinpossessionFinancialInformation1 35 false false R36.htm 100360 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Revenue Disaggregated by Product and Service Type (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesScheduleOfRevenueDisaggregatedByProductAndServiceTypeDetails Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Revenue Disaggregated by Product and Service Type (Details) Details 36 false false R37.htm 100370 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details) Details 37 false false R38.htm 100380 - Disclosure - Liquidity and Going Concern - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureLiquidityAndGoingConcernAdditionalInformationDetails Liquidity and Going Concern - Additional Information (Details) Details 38 false false R39.htm 100390 - Disclosure - Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) Details 39 false false R40.htm 100400 - Disclosure - Fair Value Measurements - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails Fair Value Measurements - Additional Information (Details) Details 40 false false R41.htm 100410 - Disclosure - Fair Value Measurements - Summary of Derivative Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3) (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfDerivativeLiabilitiesMeasuredAtFairValueUsingSignificantUnobservableInputsLevel3Details Fair Value Measurements - Summary of Derivative Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3) (Details) Details 41 false false R42.htm 100420 - Disclosure - Investment - Celularity - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureInvestmentCelularityAdditionalInformationDetails Investment - Celularity - Additional Information (Details) Details 42 false false R43.htm 100430 - Disclosure - Investments - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails Investments - Additional Information (Details) Details 43 false false R44.htm 100440 - Disclosure - Investments - NANTibody - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureInvestmentsNantibodyAdditionalInformationDetails Investments - NANTibody - Additional Information (Details) Details 44 false false R45.htm 100450 - Disclosure - Investments - NantStem - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureInvestmentsNantstemAdditionalInformationDetails Investments - NantStem - Additional Information (Details) Details 45 false false R46.htm 100460 - Disclosure - Goodwill and Intangible Assets - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails Goodwill and Intangible Assets - Additional Information (Details) Details 46 false false R47.htm 100470 - Disclosure - Goodwill and Intangible Assets - Summary of Company's Identifiable Intangible Assets (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureGoodwillAndIntangibleAssetsSummaryOfCompanySIdentifiableIntangibleAssetsDetails Goodwill and Intangible Assets - Summary of Company's Identifiable Intangible Assets (Details) Details 47 false false R48.htm 100480 - Disclosure - Goodwill and Intangible Assets - Schedule of Estimated Future Amortization Expense Related to Intangible Assets (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureGoodwillAndIntangibleAssetsScheduleOfEstimatedFutureAmortizationExpenseRelatedToIntangibleAssetsDetails Goodwill and Intangible Assets - Schedule of Estimated Future Amortization Expense Related to Intangible Assets (Details) Details 48 false false R49.htm 100490 - Disclosure - Significant Agreements and Contracts - Zhengzhou Fortune Bioscience Co., Ltd. - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureSignificantAgreementsAndContractsZhengzhouFortuneBioscienceCoLtdAdditionalInformationDetails Significant Agreements and Contracts - Zhengzhou Fortune Bioscience Co., Ltd. - Additional Information (Details) Details 49 false false R50.htm 100500 - Disclosure - Debt - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureDebtAdditionalInformationDetails Debt - Additional Information (Details) Details 50 false false R51.htm 100510 - Disclosure - Debt - Schedule of Borrowings under ACEA Significant Debt Arrangements (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureDebtScheduleOfBorrowingsUnderAceaSignificantDebtArrangementsDetails Debt - Schedule of Borrowings under ACEA Significant Debt Arrangements (Details) Details 51 false false R52.htm 100520 - Disclosure - Debt - Schedule of Future Repayments under the Contract (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureDebtScheduleOfFutureRepaymentsUnderTheContractDetails Debt - Schedule of Future Repayments under the Contract (Details) Details 52 false false R53.htm 100530 - Disclosure - Stockholders' Equity - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails Stockholders' Equity - Additional Information (Details) Details 53 false false R54.htm 100540 - Disclosure - Stock-Based Compensation - 2019 Stock Incentive Plan - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureStockbasedCompensation2019StockIncentivePlanAdditionalInformationDetails Stock-Based Compensation - 2019 Stock Incentive Plan - Additional Information (Details) Details 54 false false R55.htm 100550 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails Stock-Based Compensation - Summary of Stock Option Activity (Details) Details 55 false false R56.htm 100560 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Unit ("RSU") Activity (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitRsuActivityDetails Stock-Based Compensation - Summary of Restricted Stock Unit ("RSU") Activity (Details) Details 56 false false R57.htm 100570 - Disclosure - Stock-Based Compensation - Scilex Holding Company - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureStockbasedCompensationScilexHoldingCompanyAdditionalInformationDetails Stock-Based Compensation - Scilex Holding Company - Additional Information (Details) Details 57 false false R58.htm 100580 - Disclosure - Stock-Based Compensation - Employee Stock Purchase Plan - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureStockbasedCompensationEmployeeStockPurchasePlanAdditionalInformationDetails Stock-Based Compensation - Employee Stock Purchase Plan - Additional Information (Details) Details 58 false false R59.htm 100590 - Disclosure - Stock-Based Compensation - CEO Performance Award - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureStockbasedCompensationCeoPerformanceAwardAdditionalInformationDetails Stock-Based Compensation - CEO Performance Award - Additional Information (Details) Details 59 false false R60.htm 100600 - Disclosure - Commitments and Contingencies - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails Commitments and Contingencies - Additional Information (Details) Details 60 false false R61.htm 100610 - Disclosure - Commitments and Contingencies - Supplemental Quantitative Information Related to Leases (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesSupplementalQuantitativeInformationRelatedToLeasesDetails Commitments and Contingencies - Supplemental Quantitative Information Related to Leases (Details) Details 61 false false R62.htm 100620 - Disclosure - Commitments and Contingencies - Schedule of Operating Lease Liability Maturities (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesScheduleOfOperatingLeaseLiabilityMaturitiesDetails Commitments and Contingencies - Schedule of Operating Lease Liability Maturities (Details) Details 62 false false R63.htm 100630 - Disclosure - Income Taxes - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails Income Taxes - Additional Information (Details) Details 63 false false R64.htm 100640 - Disclosure - Net Loss Per Share - Reconciliation of Basic and Diluted Loss Per Share (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureNetLossPerShareReconciliationOfBasicAndDilutedLossPerShareDetails Net Loss Per Share - Reconciliation of Basic and Diluted Loss Per Share (Details) Details 64 false false R65.htm 100650 - Disclosure - Net Loss Per Share - Components of Outstanding Securities (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureNetLossPerShareComponentsOfOutstandingSecuritiesDetails Net Loss Per Share - Components of Outstanding Securities (Details) Details 65 false false R66.htm 100660 - Disclosure - Segment Information - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureSegmentInformationAdditionalInformationDetails Segment Information - Additional Information (Details) Details 66 false false R67.htm 100670 - Disclosure - Segment Information - Summary of Information by Reportable Segments (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/Role_DisclosureSegmentInformationSummaryOfInformationByReportableSegmentsDetails Segment Information - Summary of Information by Reportable Segments (Details) Details 67 false false R68.htm 100680 - Disclosure - Liabilities Subject to Compromise - Schedule of liability subject to compromise (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureLiabilitiesSubjectToCompromiseScheduleOfLiabilitySubjectToCompromiseDetails Liabilities Subject to Compromise - Schedule of liability subject to compromise (Details) Details 68 false false R69.htm 100690 - Disclosure - Reorganization Items, Net - Schedule of reorganization items incurred as a result of the chapter 11 (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureReorganizationItemsNetScheduleOfReorganizationItemsIncurredAsAResultOfTheChapter11Details Reorganization Items, Net - Schedule of reorganization items incurred as a result of the chapter 11 (Details) Details 69 false false R70.htm 100700 - Disclosure - Condensed Combined Debtor-In-Possession Financial Information - Schedule of Condensed Balance Sheets of Debtors (Unaudited) (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureCondensedCombinedDebtorinpossessionFinancialInformationScheduleOfCondensedBalanceSheetsOfDebtorsUnauditedDetails Condensed Combined Debtor-In-Possession Financial Information - Schedule of Condensed Balance Sheets of Debtors (Unaudited) (Details) Details 70 false false R71.htm 100710 - Disclosure - Condensed Combined Debtor-In-Possession Financial Information - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureCondensedCombinedDebtorinpossessionFinancialInformationAdditionalInformationDetails Condensed Combined Debtor-In-Possession Financial Information - Additional Information (Details) Details 71 false false R72.htm 100720 - Disclosure - Condensed Combined Debtor-In-Possession Financial Information - Schedule of Condensed Consolidated Statement of Operations of Debtors (Unaudited) (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureCondensedCombinedDebtorinpossessionFinancialInformationScheduleOfCondensedConsolidatedStatementOfOperationsOfDebtorsUnauditedDetails Condensed Combined Debtor-In-Possession Financial Information - Schedule of Condensed Consolidated Statement of Operations of Debtors (Unaudited) (Details) Details 72 false false R73.htm 100730 - Disclosure - Condensed Combined Debtor-In-Possession Financial Information - Schedule of Condensed Consolidated Statement of Cash Flows (Unaudited) (Details) Sheet http://sorrentotherapeutics.com/20230331/taxonomy/role/DisclosureCondensedCombinedDebtorinpossessionFinancialInformationScheduleOfCondensedConsolidatedStatementOfCashFlowsUnauditedDetails Condensed Combined Debtor-In-Possession Financial Information - Schedule of Condensed Consolidated Statement of Cash Flows (Unaudited) (Details) Details 73 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept TreasuryStockShares in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. srne-20230331.htm 798 [dq-0542-Deprecated-Concept] Concept TreasuryStockMember in us-gaap/2022 used in 8 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. srne-20230331.htm 1488, 1492, 1800, 1804, 1942, 1946, 2215, 2219 [dq-0542-Deprecated-Concept] Concept ResearchAndDevelopmentInProcess in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. srne-20230331.htm 2356 [dq-0542-Deprecated-Concept] Concept AccountsPayableRelatedPartiesNoncurrent in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. srne-20230331.htm 4741, 5210 [dq-0542-Deprecated-Concept] Concept AccountsReceivableRelatedParties in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. srne-20230331.htm 4979, 4983 srne-20230331.htm srne-20230331.xsd srne-20230331_cal.xml srne-20230331_def.xml srne-20230331_lab.xml srne-20230331_pre.xml srne-ex31_1.htm srne-ex31_2.htm srne-ex32_1.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true